Ageliki G Vouyouka1, K Craig Kent. 1. Division of Vascular Surgery, New York Presbyterian Hospital, Cornell University, Weill Medical School and Columbia University, College of Physicians and Surgeons, New York, NY 10021, USA. agv9002@med.cornell.edu
Abstract
BACKGROUND: Arterial disease in women will become a major issue in the near future. METHODS: A systemic review of existing literature was retrospectively conducted to collect information on the three most common entities of vascular disease: carotid atherosclerotic, abdominal aortic aneurismal, and lower extremity arterial occlusive disease. RESULTS: Vascular disease is either underdiagnosed or undertreated in women. Whether regarding cerebrovascular disease, aortic aneurysmal disease, or atherosclerosis affecting the lower extremities, natural history, clinical and physiologic patterns are different in women vs men. Current biomedical devices create challenges in endovascular procedures performed in women. Furthermore, indications for treatment of vascular disease are derived from large studies where women are often underrepresented; and, thus, may not be applicable in female vascular patients. CONCLUSIONS: Better understanding of the gender differences in vascular disease with focused randomized trials, biomedical research, and identification of gender specific medical and social risk factors will improve the clinical outcomes in female patients.
BACKGROUND: Arterial disease in women will become a major issue in the near future. METHODS: A systemic review of existing literature was retrospectively conducted to collect information on the three most common entities of vascular disease: carotid atherosclerotic, abdominal aortic aneurismal, and lower extremity arterial occlusive disease. RESULTS:Vascular disease is either underdiagnosed or undertreated in women. Whether regarding cerebrovascular disease, aortic aneurysmal disease, or atherosclerosis affecting the lower extremities, natural history, clinical and physiologic patterns are different in women vs men. Current biomedical devices create challenges in endovascular procedures performed in women. Furthermore, indications for treatment of vascular disease are derived from large studies where women are often underrepresented; and, thus, may not be applicable in female vascular patients. CONCLUSIONS: Better understanding of the gender differences in vascular disease with focused randomized trials, biomedical research, and identification of gender specific medical and social risk factors will improve the clinical outcomes in female patients.
Authors: Ashish K Jain; Gabriela Velazquez-Ramirez; Philip P Goodney; Matthew S Edwards; Matthew A Corriere Journal: Am Surg Date: 2011-07 Impact factor: 0.688
Authors: Venkataramu N Krishnamurthy; Muhammad Naeem; Timothy P Murphy; Joselyn Cerezo; Paul Gaither Jordan; Suzanne H Goldberg; Abby G Ershow; Alan T Hirsch; Niki Oldenburg; Donald E Cutlip Journal: Clin Imaging Date: 2015-09-04 Impact factor: 1.605
Authors: Prateek K Gupta; Jason N Mactaggart; Bala Natarajan; Thomas G Lynch; Shipra Arya; Himani Gupta; Xiang Fang; Iraklis I Pipinos Journal: J Vasc Surg Date: 2011-12-30 Impact factor: 4.268
Authors: Cindy P Porras; Martin Teraa; Michiel L Bots; Annemarijn R de Boer; Sanne A E Peters; Sander van Doorn; Robin W M Vernooij Journal: J Clin Med Date: 2022-06-24 Impact factor: 4.964
Authors: Birgitta Sigvant; Fredrik Lundin; Bo Nilsson; David Bergqvist; Eric Wahlberg Journal: BMC Cardiovasc Disord Date: 2011-06-30 Impact factor: 2.298
Authors: Ana Lopez-de-Andrés; Isabel Jiménez-Trujillo; Rodrigo Jiménez-García; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Napoleón Perez-Farinos; Miguel Ángel Salinero-Fort; Pilar Carrasco-Garrido Journal: Cardiovasc Diabetol Date: 2015-05-07 Impact factor: 9.951